Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Mark W Weatherall"'
Autor:
Fichman, Martin
Publikováno v:
Albion: A Quarterly Journal Concerned with British Studies, 2001 Oct 01. 33(3), 498-500.
Externí odkaz:
https://www.jstor.org/stable/4053246
Autor:
Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W. Weatherall, James J. Rucker, Michael W. Platt, Mikael H. Sodergren
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 4, Pp 616-632 (2023)
Abstract Introduction While there is increasing evidence of the effects of cannabis‐based medicinal products (CBMPs) on health‐related quality of life (HRQoL), a major limitation of the current literature is the heterogeneity of studied CBMPs. Th
Externí odkaz:
https://doaj.org/article/d62ee49e28054088a17fabbb04c94272
Autor:
Worboys, Michael
Publikováno v:
Isis, 2004 Jun . 95(2), 308-309.
Externí odkaz:
https://www.jstor.org/stable/10.1086/426239
Autor:
Lawrence, Christopher
Publikováno v:
Bulletin of the History of Medicine, 2001 Oct 01. 75(3), 588-589.
Externí odkaz:
https://www.jstor.org/stable/44445687
Autor:
Kavyesh Vivek, Zekiye Karagozlu, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mark W. Weatherall, Mikael H Sodergren
Publikováno v:
Brain and Behavior, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Introduction The primary aim of this study was to assess changes in sleep‐specific health‐related quality of life (HRQoL) for those prescribed cannabis‐based medicinal products (CBMPs) for insomnia. Methods A case series of UK patients
Externí odkaz:
https://doaj.org/article/a3e581e5239f4578802925ef8044de7a
Autor:
Kragh, Helge
Publikováno v:
The American Historical Review, 2001 Apr 01. 106(2), 644-645.
Externí odkaz:
https://www.jstor.org/stable/2651744
Autor:
Simon Erridge, Oliver Salazar, Michal Kawka, Carl Holvey, Ross Coomber, Azfer Usmani, Mohammed Sajad, Sushil Beri, Jonathan Hoare, Shaheen Khan, Mark W. Weatherall, Michael Platt, James J. Rucker, Mikael H. Sodergren
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 3, Pp 362-370 (2021)
Abstract Aim Cannabis‐based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high‐quality randomized controlled trials. The aim of this study is to analyze the early outcomes of the first series of patients
Externí odkaz:
https://doaj.org/article/054e64bcc4ca44e28126934b4cf0eba1
Autor:
Martin Fichman
Publikováno v:
Albion. 33:498-500
Autor:
Helge Kragh
Publikováno v:
The American Historical Review.
Autor:
Michael Worboys
Publikováno v:
Isis. 95:308-309